Skip to main content
OpenTrials

Clinical trial condition

Rectal Neoplasms

Explore clinical trials studying Rectal Neoplasms. Study availability and eligibility vary by location and protocol.

1,501 public trials 286 recruiting studies
Refine in advanced search Browse all conditions

Rectal Neoplasms trial results

Active, Not Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

NCT02465060

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 1411 locations
View Trial Details
Active, Not Recruiting

A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer

NCT05009069

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, China
  • The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, China
  • Zhongshan Hospital Fudan University Shanghai, China
View Trial Details
Active, Not Recruiting

Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)

NCT04793958

Conditions
Advanced Colorectal Cancer, Colonic Diseases, Colonic Neoplasms, +12 more
Locations
  • Local Institution - 010-855-E Alabaster, Alabama, United States
  • Local Institution - 010-855-B Bessemer, Alabama, United States
  • Local Institution - 010-855-D Birmingham, Alabama, United States
  • Local Institution - 010-855-A Birmingham, Alabama, United States
View all 419 locations
View Trial Details
Active, Not Recruiting

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

NCT06447662

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +29 more
Locations
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
  • Highlands Oncology Group, PA Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

NCT06607185

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
View all 45 locations
View Trial Details

Related conditions